Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient.
Paola
Piccioni
P
Luca
Laurenti
L
Michela
Tarnani
T
Patrizia
Chiusolo
C
Federica
Sorà
S
Nicola
Piccirillo
P
Giuseppe
Leone
L
Simona
Sica
S
Antonio
Grieco
G
D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine